Rating Change
Oppenheimer analysts reiterated a Outperform rating on Ovid Therapeutics Inc. (NASDAQ:OVID) on August 03, 2026.
reiterateNASDAQ:OVID
Oppenheimer Reiterates Outperform Rating on Ovid Therapeutics Inc. (OVID)
Rating Change Oppenheimer analysts reiterated a Outperform rating on Ovid Therapeutics Inc. (NASDAQ:OVID) on August 03, 2026. Market Context Ovid Therapeutics Inc.
Market Context
Ovid Therapeutics Inc. operates in the Healthcare sector. The stock currently trades at $2.33 with a market capitalization of $117.3M. The stock has gained 344.0% over the past 52 weeks.
Analyst coverage from Oppenheimer provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Ovid Therapeutics Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Ovid Therapeutics Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 03, 2026 | Oppenheimer | Outperform | N/A |
| Apr 15, 2026 | Wedbush | Outperform | N/A |
| Apr 09, 2026 | HC Wainwright & Co. | Buy | N/A |
| Mar 26, 2026 | BTIG | Buy | N/A |
| Mar 20, 2026 | Wedbush | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View OVID Stock Page
Frequently Asked Questions
What does a Outperform rating mean for OVID?
A Outperform rating from Oppenheimer reflects the analyst's outlook on Ovid Therapeutics Inc. (NASDAQ:OVID). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the OVID forecast page.